A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
Marinus Pharmaceuticals, Inc.
Start Date
March 4, 2023
End Date
November 1, 2025
Administered By
Pediatrics, Neurology
Awarded By
Marinus Pharmaceuticals, Inc.
Start Date
March 4, 2023
End Date
November 1, 2025